GLP-1 Receptor Agonists Show Promise for Treating Extragenital Lichen Sclerosus: A Case Report
This case report describes 2 patients with lichen sclerosus whose symptoms improved with glucagon-like peptide-1 receptor agonists.
Read the full articleYou might also wanna read
GLP-1 Receptor Agonists Associated With Lower Cardiovascular and Inflammatory Risks in Hidradenitis Suppurativa
As reported on MedPage Today, large retrospective study suggests that glucagon-like peptide-1 (GLP-1) receptor agonists may offer broad heal
The Newest Frontier for GLP-1s: Clearing Skin Disease
Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly. Medscape Medical News
GLP-1 Drugs May Directly Treat Skin Inflammation, New Research Suggests
Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly.
mdsc.pe·3d agoGLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease
GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large glob
GLP-1 Drugs Like Ozempic and Wegovy May Be Improving a Painful Skin Disease, Dermatologists Say
New evidence links GLP-1 drugs like Ozempic and Wegovy to significant improvements in psoriasis and hidradenitis suppurativa. Dermatologists
GLP-1 Receptor Agonists Show Promise Against Obesity Related Cancer
The post GLP-1 Receptor Agonists Show Promise Against Obesity Related Cancer appeared first on European Medical Journal .
Comments
Sign in to join the conversation.
No comments yet. Be the first.